LEISH-F2 + MPL-SE: Clinical Trials

1 trial of LEISH-F2 + MPL-SE, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow LEISH-F2 + MPL-SE: new trials by email Literature Review of LEISH-F2 + MPL-SE trials Research Report on LEISH-F2 + MPL-SE

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of the Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous Leishmaniasis
LEISH-F2 + MPL-SE, Sodium stibogluconate - Cutaneous Leishmaniasis
Phase 2CompletedAccess to Advanced Health Institute (AAHI)452009-10-012013-12-11

Conditions studied

Leishmaniasis (1)  ·  Leishmaniasis, Cutaneous (1)

Sponsors

Access to Advanced Health Institute (AAHI) (1)

Countries

Peru (1)

Top investigators

Franco Piazza, MD, MPH (1)